GastroPanel课件.ppt

Theranostic GastroPanel diagnosis and Acetium preventive treatment GastroPanel Diagnose atrophic gastritis – Acid-free stomach: low PGI and/or low PGI/PGII and high G-17 Acid-free stomach is a risk factor of gastric and oesofageal cancer Acetium capsule Binds and inactivates carcinogenic acetaldehyde (class 1 carcinogen for humans/WHO-IARC Oct 2009) in an acid-free stomach caused by atrophic gastritis or autoimmune disease Thank You for Your Attention. * * * * * * * * * * * * * * * * * * * * * * * * GastroPanel Innovation Pentti Sipponen, MD, PhD Professor Biohit Oyj, Helsinki GastroPanel for the unmet need (1) Gastrointestinal disorders are a growing medical, ethical and economic global problem and they are among the most common types of complaints made to primary care physicians worldwide and are associated with a substantial healthcare and economic burden Despite being one of the world’s largest therapeutic areas many of the diseases of the gastrointestinal tract are still poorly understood and diagnosis and therapy options are far from optimal leaving many patients dissatisfied with their current treatment GastroPanel for the unmet need (2) In addition, the ageing of the population is accompanied by severe diseases such as gastric, oesophageal and colorectal cancers as well as peptic ulcers, dementia, depression, polyneuropathy, heart attacks, strokes, anemia and osteoporosis which are causing an increasing burden for well-being and even a threat to sustainable health care GastroPanel for the unmet need (3) Biohit’s mission is to alleviate and solve these huge medical and economic problems and to become a leading supplier of unique diagnostic products and analyzing systems as well as turnkey, comprehensive GastroPanel Laboratories with special focus on the development of safe, ethical and cost-efficient diagnosis of diseases and cancer prevention of the gastrointestinal tract (/Diagnostics/Product Brochures /GastroPanel Laboratori